The prevention of osteoporosis using sequential low-dose hormone replacement therapy with estradiol-17β and dydrogesterone

Osteoporosis International

Volumn 12, Issue 4, 2001, Pages 251-258

  Lees, B ^a   Stevenson, J C ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Bone density; Hormone replacement therapy; Osteoporosis

Indexed keywords

DYDROGESTERONE PLUS ESTRADIOL; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLEEDING; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DYSMENORRHEA; FEMALE; FEMUR NECK; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; AGING; BONE DENSITY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DYDROGESTERONE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0035554517     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980170113     Document Type: Article

References (20)

1. Postmenopausal oestrogens protect against fractures of hip and distal radius
2. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of oestrogen
3. A case-control study of menopausal estrogen therapy and hip fractures
4. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss
5. The minimum effective dose of oestrogen for prevention of postmenopausal bone loss
6. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women
7. Pathophysiological mechanisms of estrogen effect on bone metabolism: Dose response relationships in early postmenopausal women
8. Changes in bone density in women starting hormone replacement therapy compared with those in women already established on hormone replacement therapy
9. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis
10. A dose-ranging study of the use of cyclical dydrogesterone with continuous 17β-oestradiol
11. A 2-year study on the beneficial effects of 17β-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: No additional unfavourable effects of dydrogesterone
12. The European Spine Phantom: A tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT
13. The impact of measurement errors on the diagnostic value of bone mass measurements: Theoretical considerations
14. An evaluation of dual-energy X-ray absorptiometry and comparison with dual photon absorptiometry
15. Dose-response evaluation of cyclic oestrogen/gestagen in postmenopausal women: Placebo controlled trial of its gynecologic and metabolic actions
16. Estrogen therapy arrests bone loss in elderly women
17. Low dosage micronised estradiol prevents bone loss
18. Low-dose esterified estrogen therapy
19. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: A randomised, controlled trial
20. The influence of thinness and smoking on bone loss and resorption on hormone replacement therapy in early postmenopausal women